IconOVir Bio
San Diego
About IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company developing oncolytic virus therapy for the treatment of patients with cancer. Its oncolytic virus platform is designed to address key limitations of first- and second-generation oncolytic viruses to help healthcare professionals provide personalized therapy for cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $77.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2021)
- Website: iconovir.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/iconovir-bio-48034 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.